Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model

Denise E. Sabatino, Christian Furlan Freguia, Raffaella Toso, Andrey Santos, Elizabeth P. Merricks, Haig H. Kazazian, Timothy C. Nichols, Rodney M. Camire, Valder R. Arruda

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds